 0 Table of Contents |
  1 Home |
  2 Workflow |
  3 Profiles |
  4 Terminology |
  5 Examples |
  6 Questionnaires |
  7 Artifacts Summary |
   7.1 Questionnaire: Cervical Colposcopy ESPBI Form |
   7.2 Questionnaire: Cervical Cytology and HPV ESPBI Form |
   7.3 Questionnaire: Cervical Histopathological Examination – ESPBI (definition) |
   7.4 Questionnaire: Cervical Pathological Diagnosis ESPBI Form |
   7.5 Cervical Cancer Screening Report (LT Cervical) |
   7.6 Cervical Composition (LT Cervical) |
   7.7 Condition: Cervical Cancer (LT Cervical) |
   7.8 Cytology Conclusion |
   7.9 DiagnosticReport: Cervical Cytology (Pap Test) |
   7.10 DiagnosticReport: Cervical Histopathology (LT Cervical) |
   7.11 DiagnosticReport: Colposcopy |
   7.12 DiagnosticReport: HPV Test |
   7.13 HPV Test Result |
   7.14 Observation: Cervical Histopathology Conclusion (LT Cervical) |
   7.15 Observation: Clinical History |
   7.16 Observation: Colposcopy Findings |
   7.17 Observation: History of Colposcopy |
   7.18 Procedure: Cervical Biopsy during Colposcopy |
   7.19 Procedure: Colposcopy |
   7.20 Cervical Biopsy Quadrant |
   7.21 Cervical Biopsy Site (LT Cervical) |
   7.22 Cervical Cytology Test Types |
   7.23 Cervical Histological Grade |
   7.24 Cervical Histopathology Diagnosis |
   7.25 Cervical Microflora |
   7.26 Cervical Pathogen |
   7.27 Cervical Sample Collection Site (LT Cervical) |
   7.28 Cervical Surgical Margins |
   7.29 Cervical TNM pR Stage |
   7.30 Cervical TNM pT Stage [RETIRED] |
   7.31 Cervix - Cytology Conclusion (LT Cervical) |
   7.32 Cervix - Cytology Preparation Method (LT Cervical) |
   7.33 Cervix - HPV Genotypes (LT Cervical) |
   7.34 Cervix - HPV Test Result (LT Cervical) |
   7.35 Colposcopy Adequacy (LT Cervical) |
   7.36 Colposcopy Swede Score Risk Category (LT Cervical) |
   7.37 Colposcopy-related Procedures (LT Cervical) |
   7.38 HPV Risk Groups ValueSet (LT Cervical) |
   7.39 HPV Vaccination Status (LT Cervical) |
   7.40 Yes / No / Unknown (SNOMED CT) (LT Cervical) |
   7.41 Cervix Scoring Instruments (LT Cervical) [RETIRED] |
   7.42 HPV Risk Groups CodeSystem (LT Cervical) |
   7.43 Cervix HPV Specimen example |
   7.44 Colposcopy Diagnostic Report example |
   7.45 Colposcopy Finding Observation example |
   7.46 Colposcopy History Observation example |
   7.47 Colposcopy Procedure example |
   7.48 Composition: Cervical Cancer Screening Episode (example) |
   7.49 Condition: Cervical Cancer pT1a1 Stage (example) |
   7.50 Cytology Conclusion Observation example |
   7.51 Cytology Diagnostic Report example |
   7.52 DiagnosticReport: Cervical Cancer Screening Report (example) |
   7.53 DiagnosticReport: Cervical Histopathology Report (example) |
   7.54 DiagnosticReport: HPV DNA Test (example) |
   7.55 HPV Result Group Observation example |
   7.56 HPV Result Observation example |
   7.57 Observation: Cervical Histopathology Conclusion – HSIL/CIN2 (example) |
   7.58 Observation: Cervical Tumor Measurement (example) |
   7.59 Observation: Clinical History - Complex (example) |
   7.60 Observation: Clinical History - Routine (example) |
   7.61 Observation: HPV Complex - Type 16 AND Medium Risk Group (example) |
   7.62 Organization: Vilniaus miesto ligoninė (example) |
   7.63 Patient: Female (example) |
   7.64 Practitioner: Dr. Petras Kazlauskas (example) |
   7.65 PractitionerRole: Dr. Petras Kazlauskas – Gynecologist (example) |
   7.66 QuestionnaireResponse: Cervical Colposcopy ESPBI (example) |
   7.67 QuestionnaireResponse: Cervical Cytology and HPV ESPBI Form (example) |
   7.68 QuestionnaireResponse: Cervical Histopathology – HSIL/CIN2, Cone Biopsy (example) |
   7.69 QuestionnaireResponse: Cervical Pathological Diagnosis ESPBI (example) |
   7.70 Specimen: Cervical Cone Biopsy (example) |